Literature DB >> 11745332

Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts.

A Pfeiffer1, A Böttcher, E Orsó, M Kapinsky, P Nagy, A Bodnár, I Spreitzer, G Liebisch, W Drobnik, K Gempel, M Horn, S Holmer, T Hartung, G Multhoff, G Schütz, H Schindler, A J Ulmer, H Heine, F Stelter, C Schütt, G Rothe, J Szöllôsi, S Damjanovich, G Schmitz.   

Abstract

The glycosylphosphatidylinositol-anchored receptor CD14 plays a major role in the inflammatory response of monocytes to lipopolysaccharide. Here, we describe that ceramide, a constituent of atherogenic lipoproteins, binds to CD14 and induces clustering of CD14 to co-receptors in rafts. In resting cells, CD14 was associated with CD55, the Fcgamma-receptors CD32 and CD64 and the pentaspan CD47. Ceramide further recruited the complement receptor 3 (CD11b/CD18) and CD36 into proximity of CD14. Lipopolysaccharide, in addition, induced co-clustering with Toll-like receptor 4, Fcgamma-RIIIa (CD16a) and the tetraspanin CD81 while CD47 was dissociated. The different receptor complexes may be linked to ligand-specific cellular responses initiated by CD14.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745332     DOI: 10.1002/1521-4141(200111)31:11<3153::aid-immu3153>3.0.co;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  75 in total

Review 1.  Role of Toll-like receptors in pathogen recognition.

Authors:  S Janssens; R Beyaert
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 2.  Ceramide-rich platforms in transmembrane signaling.

Authors:  Branka Stancevic; Richard Kolesnick
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

3.  Exogenous ceramide-1-phosphate reduces lipopolysaccharide (LPS)-mediated cytokine expression.

Authors:  Jody L Hankins; Todd E Fox; Brian M Barth; Kellee A Unrath; Mark Kester
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.

Authors:  Lutz Hamann; Christian Alexander; Cordula Stamme; Ulrich Zähringer; Ralf R Schumann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils.

Authors:  Agnieszka Krupa; Rafal Fudala; Jon M Florence; Torry Tucker; Timothy C Allen; Theodore J Standiford; Rafal Luchowski; Marek Fol; Moshiur Rahman; Zygmunt Gryczynski; Ignacy Gryczynski; Anna K Kurdowska
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

6.  Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36.

Authors:  Nadra J Nilsen; Susanne Deininger; Unni Nonstad; Frode Skjeldal; Harald Husebye; Dmitrii Rodionov; Sonja von Aulock; Thomas Hartung; Egil Lien; Oddmund Bakke; Terje Espevik
Journal:  J Leukoc Biol       Date:  2008-05-05       Impact factor: 4.962

7.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

8.  Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients.

Authors:  Mercedes Alemán; Pablo Schierloh; Silvia S de la Barrera; Rosa M Musella; María A Saab; Matías Baldini; Eduardo Abbate; María C Sasiain
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways.

Authors:  Daniel Rittirsch; Michael A Flierl; Danielle E Day; Brian A Nadeau; Firas S Zetoune; J Vidya Sarma; Clement M Werner; Guido A Wanner; Hans-Peter Simmen; Markus S Huber-Lang; Peter A Ward
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823

10.  CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Authors:  Bikash Sahay; Rebeca L Patsey; Christian H Eggers; Juan C Salazar; Justin D Radolf; Timothy J Sellati
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.